Nude mice were inoculated with 50 μM CysLT1R antagonist-pretreated HCT-116 colon cancer cells and received continued treatment (5 mg/kg/day, intraperitoneally). The gene discussed is CYSLTR1; the disease is malignant colon neoplasm.